Delivery Order SPE2DB22D3501-SPE2DB25FWB29
- Not listed
- The Defense Logistics Agency awarded a $1,030.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $3,027.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine product, with an ultimate completion date of September 15, 2025. The delivery order, issued on September 12, 2025, is a non-set-aside award executed under a competitive procurement process. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its primary location. This delivery order...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine on June 3, 2025, with a ceiling value of $3,753.42. This is a firm fixed price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,387.80 by the Defense Logistics Agency on July 14, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. The contract utilizes firm fixed pricing with an ultimate completion date of July 15, 2025. This award was competitively procured with no set-aside designation and represents a child delivery order under AmerisourceBergen's larger federal contracting...
- The Defense Logistics Agency awarded a delivery order valued at $2,061.12 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price contract, which is not set-aside, is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,469.50 of Engerix-B 20 MCG/ML vaccine on September 29, 2025, with completion scheduled for September 30, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $30,338.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. The contract, which is scheduled for completion by August 7, 2025, represents a non-set-aside competitive award and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,961.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 4, 2025. This non-competitive delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWB29Delivery Order
The Defense Logistics Agency awarded a $1,607.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, with performance in Conshohocken, Pennsylvania and completion targeted for June 17, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary vehicle for the company's comprehensive pharmaceutical and medical supply support to military healthcare systems. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, maintains extensive federal contracting relationships primarily with the Defense Logistics Agency's Medical Supply Chain, delivering a diverse portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's contract portfolio demonstrates consistent success in competitively awarded delivery orders with firm fixed pricing structures, supporting critical healthcare requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This ENGERIX-B vaccine delivery order exemplifies the company's ongoing capability to fulfill time-sensitive federal medical supply needs through its established contract infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/16/25 |